#China #Shenzhen #diabetes management #SIBIONICS #AGP & DTx

SIBIONICS Hosts 4th AGP & DTx Summit: A New Era in Diabetes Management with AI

SIBIONICS recently organized the 4th AGP & DTx Summit in Shenzhen, China, bringing together approximately 300 professionals, researchers, and industry partners from around the globe. This summit focused on the evolution of digital diabetes management and highlighted the pivotal role of artificial intelligence (AI) in enhancing the care for diabetes patients.

Theme: Beyond Glucose - Integrating AI in Diabetes Care

Under the overarching theme of 'Beyond Glucose: The Integrated Future of CGM, CKM, and AI in Diabetes Management,' the summit addressed the increasing significance of continuous glucose monitoring (CGM), continuous ketone monitoring (CKM), digital therapies, and AI in clinical practice and patient-centered care.

More than 30 international speakers participated, including renowned experts such as Andrej Janež, Sofianos Andrikopoulos, Shannon Lin, and Rodrigo Nunes Lamounier. The agenda covered a variety of critical topics related to digital therapies in diabetes management, metabolic phenotyping based on CGM data, challenges and outlooks for CGM technologies, and the expectations of patients regarding future digital diabetes care.

Summit Highlights:

In addition to the main forum, the summit featured three parallel scientific sessions: the Clinical Session, Nursing Session, and Exemplary Clinical Case Presentation Session. These formats provided a multidisciplinary platform for exchanging ideas regarding clinical research, nursing practice, real-world applications, and patient care strategies. A central theme discussed during the sessions was the shift from pure glucose monitoring to a more integrated and action-oriented approach to diabetes management.

With the evolution of AI-driven tools, CGM data is increasingly being linked with daily behaviors such as dietary choices, physical activity, and medication adherence. This approach allows users and healthcare professionals to gain better insights into glucose patterns and management needs, enhancing overall patient care.

At the summit, SIBIONICS also introduced the AI features integrated into their GS3 device, including AI Meal Insight and AI-driven Event Logging. These features are designed to simplify daily documentation and analyze the connections between lifestyle events and glucose fluctuations, ultimately supporting improved long-term adherence to treatment regimens.

As diabetes care moves beyond data collection, SIBIONICS aims to translate continuous glucose insights into clearer daily action steps for responsible diabetes management. The company's philosophy is encapsulated in their slogan: 'Beyond Glucose. Know what to do next.'

This summit marks a pivotal moment in the diabetes management landscape, reflecting the growing importance of digital solutions and AI in empowering both patients and healthcare providers. With innovations like those discussed at the AGP & DTx Summit, SIBIONICS is at the forefront of redefining how diabetes care is delivered and experienced worldwide.